New Order Issued in Federal Incretin Mimetic Litigation, Where...

The Firm is evaluating Byetta lawsuits and other product liability claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer caused by incretin mimetic...(PRWeb December 01, 2014)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb12363707.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news